Camber Pharma Launches Generic Baraclude®
Piscataway, NJ, August 21, 2015– Camber Pharmaceuticals announces that it has launched Entecavir Tablets. The drug is the generic version of Baraclude®, which is used to treat chronic Hepatitis B.
Entecavir is available from Camber in .5mg 30 and 90 count bottles and 1mg 30 count bottles.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year
- Camber Launches Mycophenolate Mofetil Capsules
- Camber Launches Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution
- Camber’s Triple Play – Featured Generics
- Big Game Commercial
- Charting a Bold Path for 2025